BioVersys

company

About

BioVersys is a privately held Swiss biopharmaceutical company.

  • 1 - 10

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€20M
Industries
Biotechnology,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active

Bioversys AG is a privately held Swiss biopharmaceutical company located in Basel that focuses on research and development of new drugs and compounds, which switch-off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. Spun out of the ETH-Zurich in 2008, we have profound technological expertise that is based on solid IP.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€20M Fr2.50M
BioVersys has raised a total of €20M Fr2.50M in funding over 2 rounds. Their latest funding was raised on Apr 14, 2021 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 14, 2021 Debt Financing €20M 1 European Investment Bank Detail
Mar 31, 2011 Seed Fr2.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
BioVersys is funded by 2 investors. European Investment Bank and BioValley Business Angels Club (BioBAC) are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Debt Financing
BioValley Business Angels Club (BioBAC) Seed